Size-controlled synthesis of gold nanoparticles and related molecular imaging contrast for computed tomography
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668. https://doi.org/10.1021/nl052396o10.1021/nl052396o ↗
2. Kircher MF, Willmann JK (2012) Molecular body imaging: MR imaging, CT, and US. Part I Principles Radiology 263:633–643. https://doi.org/10.1148/radiol.1210239410.1148/radiol.12102394 ↗
3. Pelc NJ (2014) Recent and future directions in CT imaging. Ann Biomed Eng 42:260–268. https://doi.org/10.1007/s10439-014-0974-z10.1007/s10439-014-0974-z ↗
4. Reuveni T, Motiei M, Romman Z, Popovtzer A, Popovtzer R (2011) Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine 6:2859–2864. https://doi.org/10.2147/ijn.s2544610.2147/ijn.s25446 ↗
5. Lusic H, Grinstaff MW (2013) X-ray-computed tomography contrast agents. Chem Rev 113:1641–1666. https://doi.org/10.1021/cr200358s10.1021/cr200358s ↗
6. Bernstein AL, Dhanantwari A, Jurcova M, Cheheltani R, Naha PC, Ivanc T, Shefer E, Cormode DP (2016) Improved sensitivity of computed tomography towards iodine and gold nanoparticle contrast agents via iterative reconstruction methods. Sci Rep 6:1–9. https://doi.org/10.1038/srep2617710.1038/srep26177 ↗
7. Cormode DP, Naha PC, Fayad ZA (2014) Nanoparticle contrast agents for computed tomography: a focus on micelles. Contrast Media Mol Imaging 9:37–52. https://doi.org/10.1002/cmmi.155110.1002/cmmi.1551 ↗
8. Ashton JR, West JL, Badea CT (2015) In vivo small animal micro-CT using nanoparticle contrast agents. Front Pharmacol 6:1–22. https://doi.org/10.3389/fphar.2015.0025610.3389/fphar.2015.00256 ↗
9. Ghann WE, Aras O, Fleiter T, Daniel MC (2012) Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases. Langmuir 28:10398–10408. https://doi.org/10.1021/la301694q10.1021/la301694q ↗
10. Boote E, Fent G, Kattumuri V, Casteel S, Katti K, Chanda N, Kannan R, Katti K, Churchill R (2010) Gold nanoparticle contrast in a phantom and juvenile swine. Acad Radiol 17:410–417. https://doi.org/10.1016/j.acra.2010.01.00610.1016/j.acra.2010.01.006 ↗
11. Shilo M, Reuveni T, Motiei M, Popovtzer R (2012) Nanoparticles as computed tomography contrast agents: current status and future perspectives”. Nanomedicine 7:257–269. https://doi.org/10.2217/nnm.11.19010.2217/nnm.11.190 ↗
12. Daniel MC, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology. Catalysis, and Nanotechnology. Chem Rev 104:293–346. https://doi.org/10.1021/cr030698+10.1021/cr030698+ ↗
13. Naha PC, Chhour P, Cormode DP (2015) Systematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applications. Toxicol Vitr 29:1445–1453. https://doi.org/10.1016/j.tiv.2015.05.02210.1016/j.tiv.2015.05.022 ↗
14. Dung NT, Linh NTN, Chi DL, Hoa NTH, Hung NP, Ha NT, Nam PH, Phuc NX, Tam LT, Le TLu (2021) Optical properties and stability of small hollow gold nanoparticles. RSC Adv 11:13458–13465. https://doi.org/10.1039/d0ra09417j10.1039/d0ra09417j ↗
15. Rabin O, Perez JM, Grimm J, Wojtkiewicz G, Weissleder R (2006) An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 5:118–122. https://doi.org/10.1038/nmat157110.1038/nmat1571 ↗
16. Yu SB, Watson AD (1999) Metal-based X-ray contrast media. Chem Rev 99:2353–2377. https://doi.org/10.1021/cr980441p10.1021/cr980441p ↗
17. Pannu HK, Thompson RE, Phelps J, Magee CA, Fishman EK (2005) Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol. Acad Radiol 12:576–584. https://doi.org/10.1016/j.acra.2005.01.01510.1016/j.acra.2005.01.015 ↗
18. Voert CEM, Kour RYN, Teeffelen BCJ, Ansari N, Stok KS (2020) Contrast-enhanced micro-computed tomography of articular cartilage morphology with ioversol and iomeprol. J Anat 237:1062–1071. https://doi.org/10.1111/joa.1327110.1111/joa.13271 ↗
19. Oliva MR, Erturk SM, Ichikawa T, Rocha T, Ros PR, Silverman SG, Mortele KJ (2012) Gastrointestinal tract wall visualization and distention during abdominal and pelvic multidetector ct with a neutral barium sulphate suspension: comparison with positive barium sulphate suspension and with water. JBR–BTR. 95, 237–242. https://doi.org/10.5334/jbr-btr.62810.5334/jbr-btr.628 ↗
20. Cormode DP, Jarzyna PA, Mulder WJM, Fayad ZA (2012) Modified natural nanoparticles as contrast agents for medical imaging. Adv Drug Deliv Rev 62:329–338. https://doi.org/10.1016/j.addr.2009.11.00510.1016/j.addr.2009.11.005 ↗
21. Hsu JC, Nieves LM, Betzer O, Sadan T, Noël PB, Popovtzer R, Cormode DP (2021) Nanoparticle contrast agents for X-ray imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(6):e1642. https://doi.org/10.1002/wnan.1642.Nanoparticle10.1002/wnan.1642.Nanoparticle ↗
22. Cochran ST (2005) Anaphylactoid reactions to radiocontrast media Curr. Allergy Asthma Rep 5:28–31. https://doi.org/10.1007/s11882-005-0051-710.1007/s11882-005-0051-7 ↗
23. Mruk B (2016) Renal safety of iodinated contrast media depending on their osmolarity - current outlooks. Polish J Radiol 81:157–165. https://doi.org/10.12659/PJR.89540610.12659/PJR.895406 ↗
24. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM (2006) Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 79:248–253. https://doi.org/10.1259/bjr/1316988210.1259/bjr/13169882 ↗
25. Cormode DP, Cormode DP, Skajaa T, Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, Calcagno C, Barazza A, Gordon RE, Zanzonico P, Fisher EA, Fayad ZA, Mulder WJM (2008) Nanocrystal core high-density lipoproteins- a multimodality contrast agent platform. Nano. Lett. 8:3715–3723. https://doi.org/10.1021/nl801958b10.1021/nl801958b ↗
26. Peng C, Zheng L, Chen Q, Shen M, Guo R, Wang H, Cao X, Zhang G, Shi X (2012) PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials 33:1107–1119. https://doi.org/10.1016/j.biomaterials.2011.10.05210.1016/j.biomaterials.2011.10.052 ↗
27. Jackson PA, Rahman WNWA, Wong CJ, Ackerly T, Geso M (2010) Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents. Eur J Radiol 75:104–109. https://doi.org/10.1016/j.ejrad.2009.03.05710.1016/j.ejrad.2009.03.057 ↗
28. Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC (2012) Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 41:2656–2672. https://doi.org/10.1039/c2cs15261d10.1039/c2cs15261d ↗
29. Cai QY, Kim SH, Choi KS, Kim SY, Byun SJ, Kim KW, Park SH, Juhng SK, Yoon KH (2007) Colloidal gold nanoparticles as a blood-pool contrast agent for x-ray computed tomography in mice. Invest Radiol 42:797–806. https://doi.org/10.1097/RLI.0b013e31811ecdcd10.1097/RLI.0b013e31811ecdcd ↗
30. Moghimi SM, Hunter AC, Murray JC (2014) Long-circulating and target-specific nanoparticles : theory to practice. Pharmacol Rev. 2001, 53, 283–318. https://www.researchgate.net/publication/11980988_Long-Circulating_and_Target-Specific_Nanoparticles_Theory_to_Practice
31. Eck W, Nicholson AI, Zentgraf H, Semmler W, Bartling S (2010) Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett 10:2318–2322. https://doi.org/10.1021/nl101019s10.1021/nl101019s ↗
32. Chenjie X, Tung GA, Shouheng S (2008) Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 20:4167–4169. https://doi.org/10.1021/cm800841810.1021/cm8008418 ↗
33. Fang Y, Peng C, Guo R, Zheng L, Qin J, Zhou B, Shen M, Lu X, Zhang G, Shi X (2013) Dendrimer-stabilized bismuth sulfide nanoparticles: synthesis, characterization, and potential computed tomography imaging applications. Analyst 138:3172–3180. https://doi.org/10.1039/c3an00237c10.1039/c3an00237c ↗
34. Xiao YD, Paudel R, Liu J, Ma C, Zhang ZS, Zhou SK (2016) MRI contrast agents: classification and application (Review). Int J Mol Med 38:1319–1326. https://doi.org/10.3892/ijmm.2016.274410.3892/ijmm.2016.2744 ↗
35. Thomsen HS (2006) Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 16:2619–2621. https://doi.org/10.1007/s00330-006-0495-810.1007/s00330-006-0495-8 ↗
36. Hajfathalian M, Amirshaghaghi A, Naha PC, Chhour P, Hsu JC, Douglas K, Dong Y, Sehgal CM, Tsourkas A, Neretina S, Cormode DP (2018) Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging. Nanoscale 10:18749–18757. https://doi.org/10.1039/c8nr05203d10.1039/c8nr05203d ↗
37. Cole LE, Ross RD, Tilley JM, Vargo-Gogola T, Roeder RK (2015) Gold nanoparticles as contrast agents in X-ray imaging and computed tomography. Nanomedicine 10:321–341. https://doi.org/10.2217/nnm.14.17110.2217/nnm.14.171 ↗
38. Oumano M, Russell L, Salehjahromi M, Shanshan L, Sinha N, Ngwa W, Yu H (2021) CT imaging of gold nanoparticles in a human-sized phantom. J Appl Clin Med Phys 22:337–342. https://doi.org/10.1002/acm2.1315510.1002/acm2.13155 ↗
39. Mieszawska AJ, Mulder WJM, Fayad ZA, Cormode DP (2013). Mol. Pharmaceutics. 10, 831–84710.1021/mp3005885 ↗
40. Kiessling F, Pichler BJ, Hauff P (2017) Small animal imaging. Springer Cham. https://doi.org/10.1007/978-3-319-42202-210.1007/978-3-319-42202-2 ↗
41. Haiss W, Thanh NTK, Aveyard J, Fernig DG (2007) Determination of size and concentration of gold nanoparticles from UV-Vis spectra. Anal Chem 79:4215–4221. https://doi.org/10.1021/ac070208410.1021/ac0702084 ↗
42. Dong YC, Hajfathalian M, Maidment PSN, Hsu JC, Naha PC, Si-Mohamed S, Breuilly M, Kim J, Chhour P, Douek P, Litt HI, Cormode DP (2019) Effect of gold nanoparticle size on their properties as contrast agents for computed tomography. Sci. Rep. 9:14912. https://doi.org/10.1038/s41598-019-50332-810.1038/s41598-019-50332-8 ↗
43. Chhour P, Kim J, Benardo B, Tovar A, Mian S, Litt HI, Ferrari VA, Cormode DP (2017) Effect of gold nanoparticle size and coating on labeling monocytes for CT tracking. Bioconjugate Chem 28:260–269. https://doi.org/10.1021/acs.bioconjchem.6b0056610.1021/acs.bioconjchem.6b00566 ↗
44. Khademi S, Sarkara S, Kharrazid S, Aminie SM, Zadehf AS, Ay MR, Ghadiri H (2017) Evaluation of size, morphology, concentration, and surface effect of gold nanoparticles on X-ray attenuation in computed tomography. Phys Medica 45:127–133. https://doi.org/10.1016/j.ejmp.2017.12.00110.1016/j.ejmp.2017.12.001 ↗
45. Y Dou Y Guo X Li X Li S Wang L Wang G Lv X Zhang H Wang X Gong and, 2016 J Chang Size-tuning ionization to optimize gold nanoparticles for simultaneous enhanced CT imaging and radiotherapy ACS Nano 10 2536 2548 https://doi.org/10.1021/acsnano.5b0747310.1021/acsnano.5b07473 ↗
46. Ross RD, Cole LE, Tilley JMR, Roeder RK (2014) Effects of functionalized gold nanoparticle size on X-ray attenuation and substrate binding affinity. Chem Mater 26:1187–1194. https://doi.org/10.1021/cm403561610.1021/cm4035616 ↗
47. Hirn S, Behnke MS, Schleh C, Wenk A, Lipka J, Schäffler M, Takenaka S, Möller W, Schmid G, Simon U, Kreyling WG (2011) Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77:407–416. https://doi.org/10.1016/j.ejpb.2010.12.02910.1016/j.ejpb.2010.12.029 ↗
48. Takeuchi I, Nobata S, Oiri N, Tomoda K, Makino K (2017) Biodistribution and excretion of colloidal gold nanoparticles after intravenous injection: effects of particle size. Biomed Mater Eng 28:315–323. https://doi.org/10.3233/BME-17167710.3233/BME-171677 ↗
49. Fratoddi I, Venditti I, Cametti C, Russo MV (2017) Gold nanoparticles and gold nanoparticle-conjugates for delivery of therapeutic molecules. Progress and challenges. J Mater Chem B 2:4204–4220. https://doi.org/10.1039/c4tb00383g10.1039/c4tb00383g ↗
50. Lu LT, Dung NT, Tung LD, Thanh CT, Quy OK, Chuc NV, Maenosono S, Thanh NTK (2015) Synthesis of magnetic cobalt ferrite nanoparticles with controlled morphology, monodispersity and composition: the influence of solvent, surfactant, reductant and synthetic conditions. Nanoscale 7:19596–19610. https://doi.org/10.1039/c5nr04266f10.1039/c5nr04266f ↗
51. Yamashita Y, Miyahara R, Sakamoto K (2017) Emulsion and emulsification technology. Elsevier Inc. Chapter 28, 489–506. https://doi.org/10.1016/B978-0-12-802005-0.00028-810.1016/B978-0-12-802005-0.00028-8 ↗
52. Fodjo EK, Canlier A, Kong C, Yurtsever A, Guillaume PL, Patrice FT, Abe M, Tohei T, Sakai A (2018) Facile synthesis route of Au-Ag nanostructures soaked in PEG. Adv Nanoparticles 7:37–45. https://doi.org/10.4236/anp.2018.7200410.4236/anp.2018.72004 ↗
53. Novak JP, Feldheim DL (2000) Assembly of phenylacetylene-bridged silver and gold nanoparticle arrays. JACS 122:3979–3980. https://doi.org/10.1021/ja000477a10.1021/ja000477a ↗
54. Kalyan Kamal SS, Vimala J, Sahoo PK, Ghosal P, Ram S, Durai L (2014) A green chemical approach for synthesis of shape anisotropic gold nanoparticles. Int Nano Lett 4:109–115. https://doi.org/10.1007/s40089-014-0109-410.1007/s40089-014-0109-4 ↗
55. Ha Pham TT, Dien ND, Vu XH (2021) Facile synthesis of silver/gold alloy nanoparticles for ultra-sensitive rhodamine B detection. RSC Adv 11:21475–21488. https://doi.org/10.1039/d1ra02576g10.1039/d1ra02576g ↗
56. Losso JN, Khachatryan A, Ogawa M, Godber JS, Shih F (2005) Random centroid optimization of phosphatidylglycerol stabilized lutein-enriched oil-in-water emulsions at acidic pH. Food Chem 92:737–744. https://doi.org/10.1016/j.foodchem.2004.12.02910.1016/j.foodchem.2004.12.029 ↗
57. Zhao HY, Liu S, He J, Pan CC, Li H, Zhou ZY, Ding Y, Huo D, Hu Y (2015) Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease. Biomaterials 51:194–207. https://doi.org/10.1016/j.biomaterials.2015.02.01910.1016/j.biomaterials.2015.02.019 ↗
58. Chen Q, Li K, Wen S, Liu H, Peng C, Cai H, Shen M, Zhang G, Shi X (2013) Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials 34:5200–5209. https://doi.org/10.1016/j.biomaterials.2013.03.00910.1016/j.biomaterials.2013.03.009 ↗
59. Liu H, Li K, Wen S, Liu H, Peng C, Cai H, Shen M, Zhang G, Shi X (2013) Targeted tumor computed tomography imaging using low-generation dendrimer-stabilized gold nanoparticles. Chem - A Eur J 19:6409–6416. https://doi.org/10.1002/chem.20120461210.1002/chem.201204612 ↗
60. Li J, Zheng L, Cai H, Sun W, Shen M, Zhang G, Shi X (2013) Facile one-pot synthesis of Fe3O4@Au composite nanoparticles for dual-mode MR/CT imaging applications. ACS Appl Mater Interfaces 5:10357–10366. https://doi.org/10.1021/am403452610.1021/am4034526 ↗
61. Xiao T, Wen S, Wang H, Liu H, Shen M, Zhao J, Zhang G, Shi X (2013) Facile synthesis of acetylated dendrimer-entrapped gold nanoparticles with enhanced gold loading for CT imaging applications. J Mater Chem B 1:2773–2780. https://doi.org/10.1039/c3tb20399a10.1039/c3tb20399a ↗
62. Ajeesh M, Francis BF, Annie J, Varma PRH (2010) Nano iron oxide-hydroxyapatite composite ceramics with enhanced radiopacity. J Mater Sci Mater Med 21:1427–1434. https://doi.org/10.1007/s10856-010-4005-910.1007/s10856-010-4005-9 ↗
63. Rotello V (2004) Nanoparticles building blocks for nanotechnology nanostructure science and technology. Nanostructure Sci. Technol. https://doi.org/10.1007/978-1-4419-9042-610.1007/978-1-4419-9042-6 ↗